Addex surges on upbeat data from Parkinson's drug trial FierceBiotech Addex Therapeutics' ($ADXN) stock price has soared after the Swiss biotech reported positive data from a mid-stage trial of its Parkinson's drug and its chief executive talked up his efforts to strike a collaboration deal. The stock closed Thursday up ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment